Hua Zhu (David) Ke PhD
Vice President, Bone Research, New Medicines. UCB Pharma, 208 Bath Road, Slough, Berkshire SL1 3WE, UK. Adjunct Professor, Department of Radiobiology, Division of Radiobiology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Bone biology, osteoporosis, and fracture healing. Research into estrogen receptor modulators, EP2 and EP4 receptor agonists, RANKL antibody (denosumab), sclerostin antibody (romosozumab), wnt signalling and bone metabolism.
w: http://www.ucbpharma.co.uk/r-d
t: +44 (0) 1753 447598
The Bloomsbury Centre for Skeletal Research 